University Hospital Translational Hospital

Cleveland HeartLab, Inc. is a leading provider of diagnostic services specializing in cardiometabolic disorders. As the base for Quest's first national center of excellence in this field, Cleveland HeartLab offers innovative blood and urine biomarkers that provide a comprehensive assessment of cardiovascular risk. Their collaboration with Cleveland Clinic allows them to offer diagnostic services based on cutting-edge research in inflammation and other areas of medicine. With a focus on innovation, education, and clinical references, Cleveland HeartLab is committed to advancing the understanding and identification of cardiovascular risk. Their research and development program, in partnership with renowned academic and medical institutions, brings unique biomarker technologies to the market. By measuring inflammation levels and utilizing a multi-marker approach, they aim to uncover hidden risks that may be missed by standard lipid testing, ultimately helping patients and physicians nationwide in the prevention and management of heart disease.Generated from the website

C Etec Resources is a reputable company based in Cleveland, OH that specializes in providing a wide range of technical solutions and resources to businesses and organizations. With a focus on efficiency and innovation, C Etec Resources offers tailored services to meet the unique needs of each client, ensuring seamless integration and support for their technological needs. Generated from their business information

Cleveland HeartLab, based in Cleveland, OH, is a leading provider of diagnostic services focused on identifying hidden risks of heart disease for patients and physicians nationwide. They offer simple blood and urine biomarkers that provide a comprehensive view of cardiovascular risk, partnering with institutions like the Cleveland Clinic to advance discoveries in heart disease. With a strong emphasis on innovation, education, and research, Cleveland HeartLab is dedicated to bringing unique biomarker technologies to market to help predict cardiovascular events more accurately than traditional lipid testing. Their commitment to advancing cardiovascular health is evident through collaborations with industry leaders and ongoing efforts to educate the community on the latest advancements in cardiovascular risk assessment. Generated from the website